These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 28754450)

  • 1. Pathogenesis of biliary fibrosis.
    Pinzani M; Luong TV
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1279-1283. PubMed ID: 28754450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholangiocytes in the pathogenesis of primary sclerosing cholangitis and development of cholangiocarcinoma.
    Chung BK; Karlsen TH; Folseraas T
    Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1390-1400. PubMed ID: 28844951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile duct epithelia as target cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Dienes HP; Lohse AW; Gerken G; Schirmacher P; Gallati H; Löhr HF; Meyer zum Büschenfelde KH
    Virchows Arch; 1997 Aug; 431(2):119-24. PubMed ID: 9293893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary Biliary Cholangitis: Its Pathological Characteristics and Immunopathological Mechanisms.
    Tsuneyama K; Baba H; Morimoto Y; Tsunematsu T; Ogawa H
    J Med Invest; 2017; 64(1.2):7-13. PubMed ID: 28373632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.
    Kawata K; Kobayashi Y; Gershwin ME; Bowlus CL
    Clin Rev Allergy Immunol; 2012 Dec; 43(3):230-41. PubMed ID: 22689287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative histologic features among liver biopsies with biliary-pattern injury and confirmed clinical diagnoses.
    Yu S; Vidal B; Peric M; Rosenbaum MW; Cates JMM; Gonzalez RS
    Hum Pathol; 2024 Apr; 146():8-14. PubMed ID: 38479481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infiltration of inflammatory cells expressing mitochondrial proteins around bile ducts and in biliary epithelial layer may be involved in the pathogenesis in primary biliary cirrhosis.
    Sasaki M; Kakuda Y; Miyakoshi M; Sato Y; Nakanuma Y
    J Clin Pathol; 2014 Jun; 67(6):470-6. PubMed ID: 24407434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrotic Events in the Progression of Cholestatic Liver Disease.
    Wu H; Chen C; Ziani S; Nelson LJ; Ávila MA; Nevzorova YA; Cubero FJ
    Cells; 2021 May; 10(5):. PubMed ID: 34062960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology.
    Ludwig J; Czaja AJ; Dickson ER; LaRusso NF; Wiesner RH
    Liver; 1984 Apr; 4(2):105-16. PubMed ID: 6727581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratin 7 expression in hepatic cholestatic diseases.
    Sakellariou S; Michaelides C; Voulgaris T; Vlachogiannakos J; Manesis E; Tiniakos DG; Delladetsima I
    Virchows Arch; 2021 Oct; 479(4):815-824. PubMed ID: 34312700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls.
    Si L; Whiteside TL; Schade RR; Starzl TE; Van Thiel DH
    J Clin Immunol; 1984 Jul; 4(4):262-72. PubMed ID: 6611346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cholestatic liver diseases: clues from histopathology for pathogenesis.
    Pollheimer MJ; Fickert P; Stieger B
    Mol Aspects Med; 2014 Jun; 37():35-56. PubMed ID: 24141039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathology of primary biliary cirrhosis and autoimmune cholangitis.
    Ludwig J
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Aug; 14(4):601-13. PubMed ID: 10976017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of concomitant expression of ICAM-1 and HLA-DR on bile duct cells from patients with primary sclerosing cholangitis and primary biliary cirrhosis.
    Broomé U; Hultcrantz R; Scheynius A
    Scand J Gastroenterol; 1993 Feb; 28(2):126-30. PubMed ID: 8095102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apoptosis of biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis.
    Tinmouth J; Lee M; Wanless IR; Tsui FW; Inman R; Heathcote EJ
    Liver; 2002 Jun; 22(3):228-34. PubMed ID: 12100573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyr61 Alleviates Cholangitis by Inhibiting Cytotoxic Effects of CD8
    Cheng TC; Li H; Luo X; Ju LL; Chen L; Shao JG; She YJ; Li M; Bian ZL
    Curr Med Sci; 2021 Dec; 41(6):1205-1213. PubMed ID: 34787784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of cholestatic disease in 2017.
    de Vries E; Beuers U
    Liver Int; 2017 Jan; 37 Suppl 1():123-129. PubMed ID: 28052628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
    Sasaki M; Nakanuma Y
    Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TGR5: pathogenetic role and/or therapeutic target in fibrosing cholangitis?
    Keitel V; Reich M; Häussinger D
    Clin Rev Allergy Immunol; 2015 Jun; 48(2-3):218-25. PubMed ID: 25138774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cholestatic liver diseases].
    Thimme R; Opitz OG; Blum HE; Kreisel W
    Ther Umsch; 2004 Aug; 61(8):521-7. PubMed ID: 15457969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.